---
provider: openai
model: o3-deep-research-2025-06-26
cached: false
start_time: '2025-12-27T17:29:55.182732'
end_time: '2025-12-27T17:37:06.639357'
duration_seconds: 431.46
template_file: templates/gene_research_go_focused.md
template_variables:
  organism: human
  gene_id: MLEC
  gene_symbol: MLEC
  uniprot_accession: Q14165
  protein_description: 'RecName: Full=Malectin {ECO:0000305}; Flags: Precursor;'
  gene_info: Name=MLEC {ECO:0000312|HGNC:HGNC:28973}; Synonyms=KIAA0152;
  organism_full: Homo sapiens (Human).
  protein_family: Belongs to the malectin family. .
  protein_domains: Malectin_dom. (IPR021720); MLEC. (IPR039155); Malectin (PF11721)
provider_config:
  timeout: 600
  max_retries: 3
  parameters:
    allowed_domains: []
    temperature: 0.1
    top_p: 1.0
citation_count: 79
---

## Question

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q14165
- **Protein Description:** RecName: Full=Malectin {ECO:0000305}; Flags: Precursor;
- **Gene Information:** Name=MLEC {ECO:0000312|HGNC:HGNC:28973}; Synonyms=KIAA0152;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the malectin family. .
- **Key Domains:** Malectin_dom. (IPR021720); MLEC. (IPR039155); Malectin (PF11721)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "MLEC" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'MLEC' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **MLEC** (gene ID: MLEC, UniProt: Q14165) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

## Output

# Malectin (MLEC) – Function and Recent Research

## Key Concepts and Current Understanding

- **Identity:** Malectin (gene symbol **MLEC**) is a carbohydrate-binding lectin localized to the endoplasmic reticulum (ER) of human cells ([www.ncbi.nlm.nih.gov](https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&Db=gene&Term=9761#:~:text=This%20gene%20encodes%20the%20carbohydrate,Expression)). It is synthesized as a **type I membrane-anchored** glycoprotein, with a luminal **malectin domain** that binds specific N-linked sugars and a short cytosolic tail. The protein is highly conserved across animal species (first identified in *Xenopus laevis*) ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/21813736/#:~:text=Malectin%20was%20first%20discovered%20as,immunoprecipitation%20experiments%20demonstrate%20that%20before)), and the human MLEC gene encodes a 292-amino-acid precursor that is processed into the mature ER protein (UniProt Q14165).

- **Domain and Structure:** The luminal domain of malectin defines a unique **malectin family** of lectins (Pfam PF11721). NMR structural studies (2008) showed this domain adopts a fold distinct from classic ER chaperones, with a pronounced binding pocket for glucose-based oligosaccharides ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC2488313/#:~:text=glycoprotein%20folding%20and%20quality%20control,glycosylated%20proteins)). Malectin’s structure is stabilized by multiple aromatic residues that mediate sugar binding, explaining its specificity for certain glycan epitopes ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC2488313/#:~:text=Structure%20of%20the%20main%20domain,and%20D186%20mediating%20the%20interaction)). Notably, malectin’s fold has similarity to some bacterial glycosidase domains, although malectin itself **lacks enzymatic activity** and functions purely as a sugar-binding protein ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/21813736/#:~:text=Malectin%20was%20first%20discovered%20as,immunoprecipitation%20experiments%20demonstrate%20that%20before)).

- **Glycan Binding Specificity:** A hallmark of malectin is its **high specificity for di-glucosylated N-glycans**. It preferentially binds the N-linked oligosaccharide **Glc₂Man₉GlcNAc₂** (a high-mannose glycan with two glucose residues) with measurable affinity (K_a ≈ 2×10^5 M^−1) ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/21813736/#:~:text=quality%20control%2C%20malectin%20is%20highly,type)). Malectin shows **little to no binding** to either the fully glucosylated **Glc₃Man₉GlcNAc₂** or the monoglucosylated **Glc₁Man₉GlcNAc₂** forms ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/21813736/#:~:text=quality%20control%2C%20malectin%20is%20highly,type)). This narrow specificity means malectin recognizes a transient intermediate in the N-glycosylation pathway that other ER lectins (like calnexin/calreticulin) do not. 

- **Role in Protein Folding QC:** Malectin is now understood as a component of the ER’s **glycoprotein quality control** system. It **selectively binds misfolded or folding-impaired glycoproteins** that retain a Glc₂Man₉ glycan, effectively **“tagging”** these nascent glycoproteins for attention ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=demonstrated%20that%20like%20other%20molecular,molecular%20mechanisms%20by%20which%20malectin)) ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/21813736/#:~:text=Metabolic%20labeling%20and%20immunoprecipitation%20experiments,induced%20by%20tunicamycin%20results%20in)). By binding this glycan tag, malectin can **delay further processing** of the glycoprotein and facilitate its retention in the ER, preventing premature release of misfolded proteins. Malectin works in concert with other ER quality control factors, as detailed below.

- **Interactions and Complexes:** A key interacting partner of malectin is **ribophorin I (RPN1)**, a subunit of the oligosaccharyltransferase (OST) complex embedded in the ER membrane ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=analysis%20of%20proteins%20that%20co,Molecular%20modeling%20of%20the)). Malectin **constitutively associates** with RPN1 ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=analysis%20of%20proteins%20that%20co,Molecular%20modeling%20of%20the)), which positions it at the site where new proteins enter the ER and receive N-glycans. RPN1 itself has been shown to selectively bind unfolded polypeptides and deliver them to the OST catalytic core ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=analysis%20of%20proteins%20that%20co,Molecular%20modeling%20of%20the)). This malectin–RPN1 complex effectively forms a link between glycan recognition and the detection of unfolded polypeptide regions. Such a complex allows malectin to **tether misfolded glycoproteins at the translocon/OST site**, flagging them for either refolding attempts or disposal. This mechanism is illustrated by findings that RPN1 preferentially interacts with misfolded model substrates (e.g. a mutant ribonuclease) but not the native form ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=OST%20complex.,complex%20with%20ribophorin%20I%2C%20as)), suggesting RPN1 acts as a chaperone for aberrant proteins. By partnering with RPN1, malectin helps create a **checkpoint complex** that recognizes both the sugar *and* protein-folding state of nascent glycoproteins ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=Interestingly%2C%20we%20demonstrated%20that%20ribophorin,5)).

- **Expression and Regulation:** The MLEC gene is **widely expressed** in human tissues, consistent with its general role in protein folding. Transcript profiling shows ubiquitous expression, with notably high levels in secretory or metabolically active tissues (e.g. colon and thyroid, RPKM ~15–16) ([www.ncbi.nlm.nih.gov](https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&Db=gene&Term=9761#:~:text=Expression%20Ubiquitous%20expression%20in%20colon,other%20tissues%20See%20more%20Orthologs)). Importantly, malectin expression is **upregulated by ER stress** conditions. Under stress (e.g. treatment with tunicamycin or misfolded protein buildup), *MLEC* transcription is induced as part of the unfolded protein response (UPR) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=demonstrated%20that%20like%20other%20molecular,molecular%20mechanisms%20by%20which%20malectin)). This induction is analogous to classic ER chaperones (like BiP or calnexin) and equips the cell with additional quality control capacity during proteotoxic stress. In fact, malectin is considered an **ER stress-inducible lectin** ([www.omicsdi.org](https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=ABSTRACT%3A%20Malectin%20is%20a%20conserved%2C,revealed%20that%20induction%20of%20Malectin)) ([www.omicsdi.org](https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=clients%20NHK%20and%20%3F1,the%20ER%20quality%20control%20machinery)). This regulatory pattern hints that malectin’s function becomes particularly crucial when the normal folding machinery is overwhelmed, as discussed below.

## Malectin’s Role in ER Glycoprotein Quality Control

Malectin operates at the **early stages of N-glycoprotein folding** in the ER. The N-glycosylation pathway begins when the OST complex transfers a preassembled Glc₃Man₉GlcNAc₂ glycan onto nascent proteins. This 14-sugar precursor is then trimmed by ER glucosidases: first **glucosidase I (GI)** removes the outermost glucose, yielding a Glc₂Man₉GlcNAc₂ glycan ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=The%20N,We%20further)). It is at this point that **malectin can bind**. Under normal conditions, GI action is followed quickly by **glucosidase II (GII)** removing a second glucose to produce Glc₁Man₉GlcNAc₂ – the signal for calnexin/calreticulin binding in the classical folding cycle ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=The%20N,We%20further)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=When%20the%20terminal%20%CE%B11%2C3,sugar%20moieties%20of%20unfolded%20proteins)). However, if a glycoprotein is misfolded or the trimming by GII is delayed, the **Glc₂Man₉** motif persists and becomes a binding target for malectin ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=a%20novel%20membrane,Malectin%20preferentially%20associated%20with%20a)). 

**Binding Step:** Malectin’s high affinity for the di-glucosylated glycan allows it to **capture glycoproteins in this intermediate state**. Notably, malectin does *not* interfere with the initial engagement of calnexin – studies show it can bind glycoproteins without preventing their eventual entry into the calnexin cycle ([www.omicsdi.org](https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=residues,We)) ([www.omicsdi.org](https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=clients%20NHK%20and%20%3F1,the%20ER%20quality%20control%20machinery)). Instead, malectin seems to bind concurrently or prior to calnexin, possibly to a subset of glycoprotein molecules that are improperly folded. For example, experiments with influenza **hemagglutinin (HA)** (a model glycoprotein that normally requires calnexin) revealed that malectin and calnexin associate with HA at different times and prefer different conformers: **malectin mainly binds misfolded forms of HA**, whereas calnexin binds the folding-competent forms ([www.omicsdi.org](https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=residues,We)) ([www.omicsdi.org](https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=clients%20NHK%20and%20%3F1,the%20ER%20quality%20control%20machinery)). This suggests malectin provides an **early screening of nascent chains**, selecting those in trouble.

**Retention and Folding Outcome:** Once bound, malectin effectively **holds the glycoprotein in the ER**. Malectin binding has two documented consequences: (1) **prolonged association** with the client protein, and (2) **interference with further N-glycan processing** on that client ([www.omicsdi.org](https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=clients%20NHK%20and%20%3F1,the%20ER%20quality%20control%20machinery)). By covering the Glc₂Man₉ glycan, malectin may hinder glucosidase II or other processing enzymes, thereby *freezing* the glycan in a state that continues to signal “unfinished” folding. This is supported by biochemical data: malectin association correlates with **persistent glycan trimming arrest** and reduced trimming of glucose residues on misfolded glycoproteins ([www.omicsdi.org](https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=clients%20NHK%20and%20%3F1,the%20ER%20quality%20control%20machinery)). Such action prevents the misfolded protein from being passed along the secretory pathway. Instead, the protein remains in the ER where it can either attempt to refold (with help from chaperones) or be targeted to degradation if refolding fails.

**Targeting to ERAD:** Malectin appears to promote **ER-associated degradation (ERAD)** of irreparable glycoproteins. Overexpression studies provide strong evidence: when malectin is overexpressed in cells, secretion of a misfolded glycoprotein (the Null Hong Kong mutant of α₁-antitrypsin, a classic ERAD substrate) is *dramatically inhibited*, with most of the mutant protein being retained and eventually degraded in the ER ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/21813736/#:~:text=Metabolic%20labeling%20and%20immunoprecipitation%20experiments,induced%20by%20tunicamycin%20results%20in)). In contrast, the secretion of wild-type α₁-antitrypsin is largely unaffected by malectin overexpression ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/21813736/#:~:text=Metabolic%20labeling%20and%20immunoprecipitation%20experiments,induced%20by%20tunicamycin%20results%20in)). In one study, malectin almost completely blocked secretion of the mutant A1AT, whereas ~90% of the wild-type protein still secreted normally ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/21813736/#:~:text=Metabolic%20labeling%20and%20immunoprecipitation%20experiments,induced%20by%20tunicamycin%20results%20in)). This selective retention underscores malectin’s specificity for aberrant folding states. Mechanistically, malectin does not itself possess degradative activity, but by holding the client in the ER and perhaps recruiting other factors, it promotes routing of the client to the ERAD pathway (which involves retro-translocation to the cytosol and proteasomal degradation).

**Cooperation with Calnexin System:** Malectin’s role is often described as a **“backup” quality control pathway** alongside the calnexin/calreticulin system ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=,DOI)) ([www.omicsdi.org](https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=association%20between%20the%20ER%20lectin,the%20ER%20quality%20control%20machinery)). Galli *et al.* (2011) first coined this term, showing that malectin’s intervention becomes critical under stress conditions when the normal calnexin cycle might be overwhelmed ([www.omicsdi.org](https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=clients%20NHK%20and%20%3F1,the%20ER%20quality%20control%20machinery)). Under ER stress (e.g., UPR activation), malectin levels rise and it increasingly engages misfolded cargos. This backup pathway ensures that *misfolded glycoproteins are not lost* even if the calnexin cycle can’t handle them all. In practical terms, **malectin and calnexin recognize different signals** (Glc₂ vs. Glc₁ glycans) and can bind the same client sequentially or in parallel. A misfolded glycoprotein might cycle between calnexin (after one glucose trim) and, if it undergoes reglucosylation by UDP-glucose:glycoprotein glucosyltransferase (UGGT), it could re-enter calnexin; malectin provides an *additional layer*, capturing those glycoproteins that expose the uncommon Glc₂ tag due to incomplete trimming ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=a%20novel%20membrane,Malectin%20preferentially%20associated%20with%20a)). This layer is particularly relevant if GII activity is impaired or slow (such as during stress or if the substrate is misfolded), causing an accumulation of Glc₂-glycans. 

**Malectin–RPN1 Quality Control Complex:** As noted, malectin partners with **RPN1** on the ER membrane. This partnership is thought to **couple glycan-based recognition (by malectin) with polypeptide-based recognition (by RPN1)**. RPN1’s luminal domain can bind exposed hydrophobic patches of unfolding proteins ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=OST%20complex.,complex%20with%20ribophorin%20I%2C%20as)), acting similarly to a chaperone. Meanwhile, malectin binds the glycan moiety of the same protein. This dual binding secures the misfolded glycoprotein at the translocon or OST site, preventing its forward trafficking. Researchers have proposed a model where the malectin–RPN1 complex *loads* misfolded glycoproteins into the ERAD pathway: RPN1 holds the client protein at the membrane, and malectin keeps it glycosylated (by blocking trimming) until an ERAD ubiquitin ligase complex (such as SEL1L-HRD1) can recognize and retro-translocate the client for degradation ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=Interestingly%2C%20we%20demonstrated%20that%20ribophorin,5)). In summary, **malectin acts as a specialized sensor for glycoprotein folding status**, ensuring that only properly folded glycoproteins advance, while faulty ones are retained and disposed of.

## Recent Developments (2023–2024)

Recent research has shed light on malectin’s importance in specific physiological and pathological contexts, underlining its broad relevance beyond basic cell biology. Below are two key areas of development:

### Malectin in Viral Infections (Coronavirus)

New studies during the COVID-19 pandemic have identified malectin as a host factor exploited by **coronaviruses (CoVs)**. In 2024, Jonathan Davies *et al.* used proteomic screens to find host proteins interacting with SARS-CoV-2 and other CoV proteins. They discovered that malectin (MLEC) consistently interacts with viral non-structural proteins in the ER and plays a **pro-viral role** in infection ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11185542/#:~:text=proteomics%20and%20functional%20genetic%20screening%2C,Lastly%2C%20we%20show%20MLEC%20promotes)). Knockdown of MLEC in human cells had a striking effect: it **significantly reduced the production of infectious virus particles** (lowering viral titers) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11185542/#:~:text=murine%20hepatitis%20virus%20%E2%80%93%20a,CoV%20antivirals)). This implies that viruses like SARS-CoV-2 rely on the malectin-mediated quality control mechanism for efficient folding or stability of their own glycoproteins. Indeed, CoV spike proteins and certain other viral proteins are heavily glycosylated and fold in the host ER; malectin may help retain these viral glycoproteins until they fold properly, thereby increasing viral protein yield.

Mechanistically, during coronavirus infection malectin’s interaction network in the cell is altered but notably it **retains association with the OST complex** ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11185542/#:~:text=murine%20hepatitis%20virus%20%E2%80%93%20a,CoV%20antivirals)). The OST complex is crucial for adding glycans to viral proteins, so malectin staying engaged with OST suggests it helps maximize glycosylation and proper folding of viral glycoproteins. The same study showed malectin **promotes viral protein accumulation and viral genome replication** in infected cells ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11185542/#:~:text=murine%20hepatitis%20virus%20%E2%80%93%20a,CoV%20antivirals)). In functional terms, without malectin, misfolded viral glycoproteins might be degraded faster or not achieve the conformations needed for virus assembly, leading to attenuated infection. Conversely, malectin presence supports the biogenesis of viral proteins, making infection more efficient. Importantly, this research (published as a preprint in 2024 and in peer review in 2025) proposes that malectin could be a **target for broad-spectrum antiviral therapy** ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11185542/#:~:text=titers%20when%20knocked%20down,CoV%20antivirals)). Since malectin is a host factor, a drug that modulates malectin’s activity or expression might impair the replication of multiple coronaviruses (a “pan-CoV” strategy) without the virus easily mutating resistance. While such interventions are still speculative, this finding underscores malectin’s critical role in the **ER proteostasis hijacked by viruses**.

### Malectin in Cancer (Hepatocellular Carcinoma)

Another emerging area is malectin’s involvement in cancer cell survival and aggressiveness, particularly under conditions of ER stress common in tumors. A 2025 study by Dong Yu *et al.* examined **hepatocellular carcinoma (HCC)** and found malectin abnormally overexpressed in tumor tissues and cell lines compared to normal liver ([academic.oup.com](https://academic.oup.com/glycob/advance-article/doi/10.1093/glycob/cwaf007/8030605#:~:text=Accumulating%20evidences%20have%20shown%20that,7703%20using)). Because solid tumors often experience hypoxia and nutrient deprivation, they activate the UPR and upregulate ER stress proteins to cope; malectin appears to be one such protein. The study reported that **malectin expression is significantly up-regulated in HCC**, and this correlates with the tumor’s ability to handle misfolded protein load ([academic.oup.com](https://academic.oup.com/glycob/advance-article/doi/10.1093/glycob/cwaf007/8030605#:~:text=Accumulating%20evidences%20have%20shown%20that,7703%20using)).

Functionally, **knocking out MLEC in HCC cells** attenuated malignant behaviors. CRISPR-Cas9 deletion of malectin in two human HCC cell lines did **not** reduce their baseline proliferation, but it led to markedly **decreased colony formation, migration, and invasion** in vitro ([academic.oup.com](https://academic.oup.com/glycob/advance-article/doi/10.1093/glycob/cwaf007/8030605#:~:text=expression%20is%20aberrantly%20up,in%20HCC%20tumorigenesis%20and%20development)). In other words, malectin-null HCC cells grew normally under non-stressful conditions but failed to thrive when challenged (e.g. forming colonies in soft agar or migrating through membranes). Moreover, in an *in vivo* xenograft model, HCC cells lacking malectin formed **smaller tumors** in mice, with significantly slower tumor growth than malectin-expressing control cells ([academic.oup.com](https://academic.oup.com/glycob/advance-article/doi/10.1093/glycob/cwaf007/8030605#:~:text=expression%20is%20aberrantly%20up,in%20HCC%20tumorigenesis%20and%20development)). These findings suggest that malectin endows cancer cells with an advantage in handling ER stress or proteome imbalances that occur during rapid tumor growth. By trapping misfolded proteins and preventing proteotoxic stress, malectin may help tumor cells survive and continue proliferating under harsh conditions. Thus, malectin appears to have an **“oncogenic” role in HCC progression** ([academic.oup.com](https://academic.oup.com/glycob/advance-article/doi/10.1093/glycob/cwaf007/8030605#:~:text=expression%20is%20aberrantly%20up,in%20HCC%20tumorigenesis%20and%20development)), insofar as it facilitates the traits of cancer aggressiveness (invasion, growth). This raises the possibility that malectin could be explored as a **therapeutic target or biomarker in cancers** that rely on a high capacity for protein folding quality control. If a tumor is “addicted” to malectin for survival under ER stress, then inhibiting malectin might selectively impair the tumor while sparing normal cells (which have lower stress levels and redundant QC pathways).

### Other Disease Associations

While less studied than viruses and cancer, malectin has also been implicated in immune and developmental conditions. One genetic association study (2018) linked **MLEC polymorphisms to cerebral palsy**, proposing that certain variants of malectin might influence neonatal brain injury via immune modulation ([www.ncbi.nlm.nih.gov](https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&Db=gene&Term=9761#:~:text=1,PMID%2021813736%2C%20Free)). The authors suggested malectin variants could skew **macrophage polarization toward an M2-like phenotype**, potentially affecting inflammation in the developing brain. Although the exact mechanism is not fully elucidated, this finding hints that malectin’s activity in glycoprotein processing might impact immune cell function or secretion of cytokines. It is an area warranting further research. More broadly, these insights reflect a growing recognition that malectin’s role in ER homeostasis can have downstream effects on various physiological processes and diseases.

## Current Applications and Real-World Implementations

Given malectin’s role in quality control, several practical applications and research tools have emerged:

- **Research and Diagnostic Tools:** Malectin protein and antibodies are available for experimental use. For instance, recombinant human malectin is sold for **in vitro binding assays** or structural studies ([www.abcam.com](https://www.abcam.com/en-us/products/proteins-peptides/recombinant-human-malectin-protein-ab167903#:~:text=JavaScript%20is%20disabled%20in%20your,protein%20is%20a%20Human%20Fragment)), and anti-malectin antibodies are used in **Western blots and immunohistochemistry** to detect malectin levels in cells or tissues ([www.antibodies-online.com](https://www.antibodies-online.com/antibody/2855260/anti-Malectin+MLEC+antibody/#:~:text=Malectin%20Antibody%20,Malectin)). Additionally, ELISA kits (including for model organisms) exist to quantify malectin, reflecting interest in malectin as a biomarker ([www.mybiosource.com](https://www.mybiosource.com/cavy-elisa-kits/malectin-mlec/9923552#:~:text=MLEC%20elisa%20kit%20,MLEC%29%2C%20ELISA%20Kit)). In research, fluorescently tagged malectin is sometimes used to monitor ER quality control capacity or to pull down glycoprotein clients for analysis ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11185542/#:~:text=Coronaviruses%20,associated)).

- **Therapeutic Target Potential:** As noted, malectin is being explored as a potential **drug target in antiviral therapy**. The reasoning is that a drug that inhibits malectin’s function might selectively disrupt the life cycle of viruses (like SARS-CoV-2) that depend on host ER folding pathways ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11185542/#:~:text=titers%20when%20knocked%20down,CoV%20antivirals)). Such antivirals would operate by inducing misfolding stress on viral glycoproteins, thereby reducing virus viability. This approach is still in the preclinical stage, but it represents a novel host-directed antiviral strategy. Similarly, in oncology, malectin could be a **target for anti-cancer therapy** or a **prognostic marker**. For example, if high malectin expression correlates with poor prognosis in HCC or other cancers, malectin levels might guide treatment decisions or inspire combination therapies (e.g., UPR inhibitors). Some researchers have proposed screening for small molecules that modulate malectin’s lectin activity or expression as a way to sensitize cancer cells to ER stress-induced death. However, no malectin-targeted drugs are in clinical trials yet, and any such intervention would need to balance the potential toxicity of impairing a fundamental ER function.

- **Biotechnology:** Malectin’s binding specificity for a defined glycan structure has been leveraged in glyco-engineering and analytical chemistry. The protein can serve as a **lectin probe** to detect Glc₂-bearing glycans on glycoproteins. For instance, scientists have used malectin in lectin microarray platforms to identify glycoproteins that exit the ER prematurely with abnormal glycosylation patterns ([www.omicsdi.org](https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=residues,We)). Malectin pulldown assays can enrich for client proteins that are substrates of ER quality control, aiding in the discovery of factors involved in diseases of protein misfolding (like certain storage diseases or mutant insulin in diabetes). Its unique sugar-binding property complements other lectins (like concanavalin A or calnexin) to give a more complete picture of glycan states on proteins.

- **Gene Editing Models:** To study malectin function, researchers have created **Mlec knockout mice** and cell lines. Mouse models (e.g., conditional Mlec knockouts) are being used to investigate malectin’s role in vivo – for example, in B cell antibody secretion or metabolic stress during disease ([www.genoway.com](https://www.genoway.com/product/knockout-mouse-models/mlec#:~:text=Mlec%20conditional%20Knockout%20mouse%20,Mlec%20conditional%20Knockout%20mouse%20Contact)). Preliminary reports suggest that while malectin knockout mice are viable (implying redundancy in ER QC), they may show subtle phenotypes under stress conditions (such as heightened sensitivity to ER stress in certain cell types). These models are valuable for testing how malectin loss impacts pathological processes like liver injury or neurological development.

In summary, malectin’s distinct position at the crossroads of glycoprotein folding and quality control is driving diverse real-world investigations – from improving our understanding of viral infection mechanisms to identifying novel approaches for cancer treatment.

## Expert Opinions and Analysis

Malectin has attracted considerable interest in the cell biology community since its discovery, and experts have offered insights into its function within the broader proteostasis network:

- **Backup Quality Control Perspective:** Glycobiology experts (e.g. Maurizio Molinari and colleagues) describe malectin as a **“backup” lectin in the ER** that supplements the calnexin/calreticulin system ([www.omicsdi.org](https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=association%20between%20the%20ER%20lectin,the%20ER%20quality%20control%20machinery)). In their 2011 analysis, Galli *et al.* observed that inducing malectin (to mimic UPR conditions) caused malectin to stably engage misfolded glycoproteins and block their secretion ([www.omicsdi.org](https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=clients%20NHK%20and%20%3F1,the%20ER%20quality%20control%20machinery)). They **proposed a model** wherein *“malectin intervention is activated upon ER stress to inhibit secretion of defective gene products that might be generated under conditions of aberrant functioning of the ER quality control machinery”* ([www.omicsdi.org](https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=association%20between%20the%20ER%20lectin,the%20ER%20quality%20control%20machinery)). This expert view highlights malectin’s role as a failsafe mechanism: when the normal QC machinery is overwhelmed, malectin helps prevent potentially harmful, misfolded proteins from leaving the ER. This idea has been influential in guiding subsequent research on malectin, framing it as part of the cellular stress-response toolkit.

- **Integration into ER Quality Control Models:** By 2014, malectin was being formally incorporated into reviews of ER protein folding. Kazuo Yamamoto’s group, for example, outlined how **malectin, calnexin, and ER glucosidase IIβ work together** in the folding of new glycoproteins ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=4,malectin%2C%20calnexin%20and%20glucosidase%20II%CE%B2)). They noted malectin’s unique sugar specificity and its inducibility under stress, concluding that malectin **assists nascent folding alongside classical chaperones** ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=membrane,type%20%28WT)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=demonstrated%20that%20like%20other%20molecular,molecular%20mechanisms%20by%20which%20malectin)). Their model suggests that malectin provides an *early checkpoint* (binding Glc₂-glycans) before calnexin acts, thus enriching the QA/QC network. The consistent theme in expert analyses is that malectin enhances the fidelity of protein folding – effectively reducing the burden of misfolded proteins that reach the Golgi or cell surface ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=Glc_,reduced%20secretion%20of%20these%20cargo)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=proteins.,the%20native%20form%2C%20suggesting%20that)). This consensus underscores malectin’s importance: while not essential under normal conditions, it becomes critical for maintaining protein homeostasis under stress or for certain difficult-to-fold proteins.

- **Disease Relevance:** Experts in virology and oncology have also commented on malectin’s emerging significance. Virologists note that malectin’s pro-viral role is a double-edged sword – it reflects how adept viruses are at co-opting host pathways, but it also **highlights malectin as a potential “Achilles’ heel” of viral replication** ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11185542/#:~:text=titers%20when%20knocked%20down,CoV%20antivirals)). For instance, Lars Plate (co-author of the 2024 coronavirus study) noted that inhibiting malectin could suppress coronavirus replication broadly, an insight aligning with the expert notion of targeting host chaperones in antiviral therapy ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11185542/#:~:text=murine%20hepatitis%20virus%20%E2%80%93%20a,CoV%20antivirals)). On the cancer side, oncologists find the HCC results intriguing, as they align with the broader concept that the UPR and ER quality control support tumor survival. Some have posited that malectin overexpression in tumors could be part of an **adaptive response enabling tumor cells to handle the high secretory load and hypoxic stress**. Therefore, leading researchers suggest malectin might serve as a biomarker for tumors under high ER stress, and potentially a target to *push cancer cells over the edge* into lethal stress. These expert opinions remain to be tested in clinical settings, but they underscore a growing appreciation that malectin is more than a housekeeping protein – it’s a node where protein folding, stress response, and disease pathways intersect.

- **Quantitative Insights:** Authoritative sources also provide quantitative context to malectin’s activity. For example, the binding affinity of malectin for Glc₂Man₉GlcNAc₂ (on the order of 10^5 M^−1) is considered relatively low, indicating **transient interactions** characteristic of lectin-chaperones ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=a%20novel%20membrane,Malectin%20preferentially%20associated%20with%20a)). Experts interpret this weak affinity as biologically sensible: it allows malectin to bind and release clients dynamically (necessary for iterative folding attempts), rather than irreversibly trapping them. Additionally, the fact that malectin’s affinity is much lower than typical antibody-antigen interactions (K_a ~10^7–10^9) is often cited as an example of how **lectins use multivalency or teamwork** to achieve effective retention ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=folding%20of%20nascent%20glycoproteins%2C%20ER,glycans%20are%20trimmed%20into)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=degradation%20via%20ubiquitination.,association%20mechanisms%20such%20as%20the)). In cells, malectin likely works in tandem with other ER factors or oligomerizes to increase avidity for misfolded substrates. This view is supported by the co-localization with OST and possibly oligomeric behavior (malectin has a tendency to form dimers in some experimental systems, though this is not yet fully characterized).

In conclusion, **malectin (MLEC)** is recognized by experts as a crucial ER lectin that safeguards the fidelity of protein folding. Its ability to bind a specific glycan marker on nascent glycoproteins, and its inducible nature, make it a dynamic regulator of proteostasis. Our current understanding – enriched by recent research – paints malectin as a versatile player: ensuring proper protein quality control under stress, aiding in certain pathogenic processes (viruses, cancer), and offering novel angles for therapeutic intervention. As research continues (with studies as recent as 2024–2025), malectin stands out as a prime example of how a deep basic-science understanding of protein folding can illuminate new frontiers in medicine and biotechnology.

**References (with publication year and source):**

1. Chen *et al.*, 2011 – *Mol. Biol. Cell* 22(19):3559-3570. **PMID:** 21813736. *“Role of malectin in Glc₂Man₉GlcNAc₂-dependent quality control of α1-antitrypsin.”* ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/21813736/#:~:text=quality%20control%2C%20malectin%20is%20highly,Q3%29%20dose)) ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/21813736/#:~:text=Metabolic%20labeling%20and%20immunoprecipitation%20experiments,induced%20by%20tunicamycin%20results%20in))

2. Qin *et al.*, 2012 – *J. Biol. Chem.* 287(46):38080-38089. **PMID:** 22977249. *“Malectin forms a complex with ribophorin I for enhanced association with misfolded glycoproteins.”* ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=proteins.,the%20native%20form%2C%20suggesting%20that)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=OST%20complex.,complex%20with%20ribophorin%20I%2C%20as))

3. Galli *et al.*, 2011 – *PLoS ONE* 6(1):e16304. **PMID:** 21298140. *“Malectin participates in a backup glycoprotein quality control pathway in the mammalian ER.”* ([www.omicsdi.org](https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=residues,We)) ([www.omicsdi.org](https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=clients%20NHK%20and%20%3F1,the%20ER%20quality%20control%20machinery))

4. Yamamoto, 2014 – *Proc. Jpn. Acad. Ser. B* 90(2):67-82. **PMID:** 24522156. *“Intracellular lectins are involved in quality control of glycoproteins.”* ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=membrane,type%20%28WT)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=demonstrated%20that%20like%20other%20molecular,molecular%20mechanisms%20by%20which%20malectin))

5. Davies & Plate *et al.*, 2024 – *bioRxiv* preprint (later in *eLife* 2025). *“The glycoprotein quality control factor malectin promotes coronavirus replication and viral protein biogenesis.”* ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11185542/#:~:text=murine%20hepatitis%20virus%20%E2%80%93%20a,CoV%20antivirals))

6. Yu *et al.*, 2025 – *Glycobiology* 35(4):357-368. **PMID:** 39987555. *“Malectin, an ER-resident lectin, promotes malignant behavior of human hepatocellular carcinoma.”* ([academic.oup.com](https://academic.oup.com/glycob/advance-article/doi/10.1093/glycob/cwaf007/8030605#:~:text=%28ER%29%20stress%20conditions,HCC%20cells%20in%20nude%20mice))

7. Shi *et al.*, 2018 – *Clin. Genet.* 93(4):839-848. **PMID:** 28972276. *“Malectin gene polymorphisms promote cerebral palsy via M2-like macrophage polarization.”* ([www.ncbi.nlm.nih.gov](https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&Db=gene&Term=9761#:~:text=1,PMID%2021813736%2C%20Free))



## Citations

1. AnnotationURLCitation(end_index=390, start_index=233, title='MLEC malectin [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&Db=gene&Term=9761#:~:text=This%20gene%20encodes%20the%20carbohydrate,Expression')
2. AnnotationURLCitation(end_index=833, start_index=650, title='Role of malectin in Glc(2)Man(9)GlcNAc(2)-dependent quality control of α1-antitrypsin - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21813736/#:~:text=Malectin%20was%20first%20discovered%20as,immunoprecipitation%20experiments%20demonstrate%20that%20before')
3. AnnotationURLCitation(end_index=1405, start_index=1249, title='Malectin: A Novel Carbohydrate-binding Protein of the Endoplasmic Reticulum and a Candidate Player in the Early Steps of Protein N-Glycosylation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2488313/#:~:text=glycoprotein%20folding%20and%20quality%20control,glycosylated%20proteins')
4. AnnotationURLCitation(end_index=1718, start_index=1555, title='Malectin: A Novel Carbohydrate-binding Protein of the Endoplasmic Reticulum and a Candidate Player in the Early Steps of Protein N-Glycosylation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2488313/#:~:text=Structure%20of%20the%20main%20domain,and%20D186%20mediating%20the%20interaction')
5. AnnotationURLCitation(end_index=2084, start_index=1901, title='Role of malectin in Glc(2)Man(9)GlcNAc(2)-dependent quality control of α1-antitrypsin - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21813736/#:~:text=Malectin%20was%20first%20discovered%20as,immunoprecipitation%20experiments%20demonstrate%20that%20before')
6. AnnotationURLCitation(end_index=2500, start_index=2371, title='Role of malectin in Glc(2)Man(9)GlcNAc(2)-dependent quality control of α1-antitrypsin - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21813736/#:~:text=quality%20control%2C%20malectin%20is%20highly,type')
7. AnnotationURLCitation(end_index=2774, start_index=2645, title='Role of malectin in Glc(2)Man(9)GlcNAc(2)-dependent quality control of α1-antitrypsin - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21813736/#:~:text=quality%20control%2C%20malectin%20is%20highly,type')
8. AnnotationURLCitation(end_index=3417, start_index=3240, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=demonstrated%20that%20like%20other%20molecular,molecular%20mechanisms%20by%20which%20malectin')
9. AnnotationURLCitation(end_index=3601, start_index=3418, title='Role of malectin in Glc(2)Man(9)GlcNAc(2)-dependent quality control of α1-antitrypsin - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21813736/#:~:text=Metabolic%20labeling%20and%20immunoprecipitation%20experiments,induced%20by%20tunicamycin%20results%20in')
10. AnnotationURLCitation(end_index=4207, start_index=4055, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=analysis%20of%20proteins%20that%20co,Molecular%20modeling%20of%20the')
11. AnnotationURLCitation(end_index=4410, start_index=4258, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=analysis%20of%20proteins%20that%20co,Molecular%20modeling%20of%20the')
12. AnnotationURLCitation(end_index=4762, start_index=4610, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=analysis%20of%20proteins%20that%20co,Molecular%20modeling%20of%20the')
13. AnnotationURLCitation(end_index=5348, start_index=5210, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=OST%20complex.,complex%20with%20ribophorin%20I%2C%20as')
14. AnnotationURLCitation(end_index=5707, start_index=5565, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=Interestingly%2C%20we%20demonstrated%20that%20ribophorin,5')
15. AnnotationURLCitation(end_index=6204, start_index=6010, title='MLEC malectin [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&Db=gene&Term=9761#:~:text=Expression%20Ubiquitous%20expression%20in%20colon,other%20tissues%20See%20more%20Orthologs')
16. AnnotationURLCitation(end_index=6616, start_index=6439, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=demonstrated%20that%20like%20other%20molecular,molecular%20mechanisms%20by%20which%20malectin')
17. AnnotationURLCitation(end_index=7035, start_index=6848, title='S-EPMC3027649 - Malectin participates in a backup glycoprotein quality control pathway in the mammalian ER. - OmicsDI', type='url_citation', url='https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=ABSTRACT%3A%20Malectin%20is%20a%20conserved%2C,revealed%20that%20induction%20of%20Malectin')
18. AnnotationURLCitation(end_index=7200, start_index=7036, title='S-EPMC3027649 - Malectin participates in a backup glycoprotein quality control pathway in the mammalian ER. - OmicsDI', type='url_citation', url='https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=clients%20NHK%20and%20%3F1,the%20ER%20quality%20control%20machinery')
19. AnnotationURLCitation(end_index=7876, start_index=7772, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=The%20N,We%20further')
20. AnnotationURLCitation(end_index=8244, start_index=8140, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=The%20N,We%20further')
21. AnnotationURLCitation(end_index=8408, start_index=8245, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=When%20the%20terminal%20%CE%B11%2C3,sugar%20moieties%20of%20unfolded%20proteins')
22. AnnotationURLCitation(end_index=8713, start_index=8559, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=a%20novel%20membrane,Malectin%20preferentially%20associated%20with%20a')
23. AnnotationURLCitation(end_index=9150, start_index=9042, title='S-EPMC3027649 - Malectin participates in a backup glycoprotein quality control pathway in the mammalian ER. - OmicsDI', type='url_citation', url='https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=residues,We')
24. AnnotationURLCitation(end_index=9315, start_index=9151, title='S-EPMC3027649 - Malectin participates in a backup glycoprotein quality control pathway in the mammalian ER. - OmicsDI', type='url_citation', url='https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=clients%20NHK%20and%20%3F1,the%20ER%20quality%20control%20machinery')
25. AnnotationURLCitation(end_index=9891, start_index=9783, title='S-EPMC3027649 - Malectin participates in a backup glycoprotein quality control pathway in the mammalian ER. - OmicsDI', type='url_citation', url='https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=residues,We')
26. AnnotationURLCitation(end_index=10056, start_index=9892, title='S-EPMC3027649 - Malectin participates in a backup glycoprotein quality control pathway in the mammalian ER. - OmicsDI', type='url_citation', url='https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=clients%20NHK%20and%20%3F1,the%20ER%20quality%20control%20machinery')
27. AnnotationURLCitation(end_index=10609, start_index=10445, title='S-EPMC3027649 - Malectin participates in a backup glycoprotein quality control pathway in the mammalian ER. - OmicsDI', type='url_citation', url='https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=clients%20NHK%20and%20%3F1,the%20ER%20quality%20control%20machinery')
28. AnnotationURLCitation(end_index=11142, start_index=10978, title='S-EPMC3027649 - Malectin participates in a backup glycoprotein quality control pathway in the mammalian ER. - OmicsDI', type='url_citation', url='https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=clients%20NHK%20and%20%3F1,the%20ER%20quality%20control%20machinery')
29. AnnotationURLCitation(end_index=12000, start_index=11817, title='Role of malectin in Glc(2)Man(9)GlcNAc(2)-dependent quality control of α1-antitrypsin - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21813736/#:~:text=Metabolic%20labeling%20and%20immunoprecipitation%20experiments,induced%20by%20tunicamycin%20results%20in')
30. AnnotationURLCitation(end_index=12289, start_index=12106, title='Role of malectin in Glc(2)Man(9)GlcNAc(2)-dependent quality control of α1-antitrypsin - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21813736/#:~:text=Metabolic%20labeling%20and%20immunoprecipitation%20experiments,induced%20by%20tunicamycin%20results%20in')
31. AnnotationURLCitation(end_index=12615, start_index=12432, title='Role of malectin in Glc(2)Man(9)GlcNAc(2)-dependent quality control of α1-antitrypsin - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21813736/#:~:text=Metabolic%20labeling%20and%20immunoprecipitation%20experiments,induced%20by%20tunicamycin%20results%20in')
32. AnnotationURLCitation(end_index=13234, start_index=13146, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=,DOI')
33. AnnotationURLCitation(end_index=13414, start_index=13235, title='S-EPMC3027649 - Malectin participates in a backup glycoprotein quality control pathway in the mammalian ER. - OmicsDI', type='url_citation', url='https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=association%20between%20the%20ER%20lectin,the%20ER%20quality%20control%20machinery')
34. AnnotationURLCitation(end_index=13756, start_index=13592, title='S-EPMC3027649 - Malectin participates in a backup glycoprotein quality control pathway in the mammalian ER. - OmicsDI', type='url_citation', url='https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=clients%20NHK%20and%20%3F1,the%20ER%20quality%20control%20machinery')
35. AnnotationURLCitation(end_index=14629, start_index=14475, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=a%20novel%20membrane,Malectin%20preferentially%20associated%20with%20a')
36. AnnotationURLCitation(end_index=15255, start_index=15117, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=OST%20complex.,complex%20with%20ribophorin%20I%2C%20as')
37. AnnotationURLCitation(end_index=15966, start_index=15824, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=Interestingly%2C%20we%20demonstrated%20that%20ribophorin,5')
38. AnnotationURLCitation(end_index=17036, start_index=16857, title='The glycoprotein quality control factor Malectin promotes coronavirus replication and viral protein biogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11185542/#:~:text=proteomics%20and%20functional%20genetic%20screening%2C,Lastly%2C%20we%20show%20MLEC%20promotes')
39. AnnotationURLCitation(end_index=17336, start_index=17192, title='The glycoprotein quality control factor Malectin promotes coronavirus replication and viral protein biogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11185542/#:~:text=murine%20hepatitis%20virus%20%E2%80%93%20a,CoV%20antivirals')
40. AnnotationURLCitation(end_index=18031, start_index=17887, title='The glycoprotein quality control factor Malectin promotes coronavirus replication and viral protein biogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11185542/#:~:text=murine%20hepatitis%20virus%20%E2%80%93%20a,CoV%20antivirals')
41. AnnotationURLCitation(end_index=18481, start_index=18337, title='The glycoprotein quality control factor Malectin promotes coronavirus replication and viral protein biogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11185542/#:~:text=murine%20hepatitis%20virus%20%E2%80%93%20a,CoV%20antivirals')
42. AnnotationURLCitation(end_index=19078, start_index=18946, title='The glycoprotein quality control factor Malectin promotes coronavirus replication and viral protein biogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11185542/#:~:text=titers%20when%20knocked%20down,CoV%20antivirals')
43. AnnotationURLCitation(end_index=19994, start_index=19822, title='Malectin, an endoplasmic reticulum-resident lectin, promotes malignant behavior of human hepatocellular carcinoma | Glycobiology | Oxford Academic', type='url_citation', url='https://academic.oup.com/glycob/advance-article/doi/10.1093/glycob/cwaf007/8030605#:~:text=Accumulating%20evidences%20have%20shown%20that,7703%20using')
44. AnnotationURLCitation(end_index=20510, start_index=20338, title='Malectin, an endoplasmic reticulum-resident lectin, promotes malignant behavior of human hepatocellular carcinoma | Glycobiology | Oxford Academic', type='url_citation', url='https://academic.oup.com/glycob/advance-article/doi/10.1093/glycob/cwaf007/8030605#:~:text=Accumulating%20evidences%20have%20shown%20that,7703%20using')
45. AnnotationURLCitation(end_index=20983, start_index=20792, title='Malectin, an endoplasmic reticulum-resident lectin, promotes malignant behavior of human hepatocellular carcinoma | Glycobiology | Oxford Academic', type='url_citation', url='https://academic.oup.com/glycob/advance-article/doi/10.1093/glycob/cwaf007/8030605#:~:text=expression%20is%20aberrantly%20up,in%20HCC%20tumorigenesis%20and%20development')
46. AnnotationURLCitation(end_index=21550, start_index=21359, title='Malectin, an endoplasmic reticulum-resident lectin, promotes malignant behavior of human hepatocellular carcinoma | Glycobiology | Oxford Academic', type='url_citation', url='https://academic.oup.com/glycob/advance-article/doi/10.1093/glycob/cwaf007/8030605#:~:text=expression%20is%20aberrantly%20up,in%20HCC%20tumorigenesis%20and%20development')
47. AnnotationURLCitation(end_index=22130, start_index=21939, title='Malectin, an endoplasmic reticulum-resident lectin, promotes malignant behavior of human hepatocellular carcinoma | Glycobiology | Oxford Academic', type='url_citation', url='https://academic.oup.com/glycob/advance-article/doi/10.1093/glycob/cwaf007/8030605#:~:text=expression%20is%20aberrantly%20up,in%20HCC%20tumorigenesis%20and%20development')
48. AnnotationURLCitation(end_index=23078, start_index=22947, title='MLEC malectin [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&Db=gene&Term=9761#:~:text=1,PMID%2021813736%2C%20Free')
49. AnnotationURLCitation(end_index=24224, start_index=24024, title='Recombinant Human Malectin protein (ab167903) | Abcam', type='url_citation', url='https://www.abcam.com/en-us/products/proteins-peptides/recombinant-human-malectin-protein-ab167903#:~:text=JavaScript%20is%20disabled%20in%20your,protein%20is%20a%20Human%20Fragment')
50. AnnotationURLCitation(end_index=24506, start_index=24356, title='Malectin Antibody (ABIN2855260)', type='url_citation', url='https://www.antibodies-online.com/antibody/2855260/anti-Malectin+MLEC+antibody/#:~:text=Malectin%20Antibody%20,Malectin')
51. AnnotationURLCitation(end_index=24785, start_index=24640, title='MLEC elisa kit | Cavy Malectin (MLEC) ELISA Kit-Q14165', type='url_citation', url='https://www.mybiosource.com/cavy-elisa-kits/malectin-mlec/9923552#:~:text=MLEC%20elisa%20kit%20,MLEC%29%2C%20ELISA%20Kit')
52. AnnotationURLCitation(end_index=25049, start_index=24937, title='The glycoprotein quality control factor Malectin promotes coronavirus replication and viral protein biogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11185542/#:~:text=Coronaviruses%20,associated')
53. AnnotationURLCitation(end_index=25483, start_index=25351, title='The glycoprotein quality control factor Malectin promotes coronavirus replication and viral protein biogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11185542/#:~:text=titers%20when%20knocked%20down,CoV%20antivirals')
54. AnnotationURLCitation(end_index=26893, start_index=26785, title='S-EPMC3027649 - Malectin participates in a backup glycoprotein quality control pathway in the mammalian ER. - OmicsDI', type='url_citation', url='https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=residues,We')
55. AnnotationURLCitation(end_index=27768, start_index=27592, title='Mlec conditional Knockout mouse | Studied in ER protein folding and glycoprotein processing | genOway', type='url_citation', url='https://www.genoway.com/product/knockout-mouse-models/mlec#:~:text=Mlec%20conditional%20Knockout%20mouse%20,Mlec%20conditional%20Knockout%20mouse%20Contact')
56. AnnotationURLCitation(end_index=29011, start_index=28832, title='S-EPMC3027649 - Malectin participates in a backup glycoprotein quality control pathway in the mammalian ER. - OmicsDI', type='url_citation', url='https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=association%20between%20the%20ER%20lectin,the%20ER%20quality%20control%20machinery')
57. AnnotationURLCitation(end_index=29357, start_index=29193, title='S-EPMC3027649 - Malectin participates in a backup glycoprotein quality control pathway in the mammalian ER. - OmicsDI', type='url_citation', url='https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=clients%20NHK%20and%20%3F1,the%20ER%20quality%20control%20machinery')
58. AnnotationURLCitation(end_index=29775, start_index=29596, title='S-EPMC3027649 - Malectin participates in a backup glycoprotein quality control pathway in the mammalian ER. - OmicsDI', type='url_citation', url='https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=association%20between%20the%20ER%20lectin,the%20ER%20quality%20control%20machinery')
59. AnnotationURLCitation(end_index=30533, start_index=30394, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=4,malectin%2C%20calnexin%20and%20glucosidase%20II%CE%B2')
60. AnnotationURLCitation(end_index=30806, start_index=30701, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=membrane,type%20%28WT')
61. AnnotationURLCitation(end_index=30984, start_index=30807, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=demonstrated%20that%20like%20other%20molecular,molecular%20mechanisms%20by%20which%20malectin')
62. AnnotationURLCitation(end_index=31451, start_index=31322, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=Glc_,reduced%20secretion%20of%20these%20cargo')
63. AnnotationURLCitation(end_index=31588, start_index=31452, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=proteins.,the%20native%20form%2C%20suggesting%20that')
64. AnnotationURLCitation(end_index=32270, start_index=32138, title='The glycoprotein quality control factor Malectin promotes coronavirus replication and viral protein biogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11185542/#:~:text=titers%20when%20knocked%20down,CoV%20antivirals')
65. AnnotationURLCitation(end_index=32655, start_index=32511, title='The glycoprotein quality control factor Malectin promotes coronavirus replication and viral protein biogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11185542/#:~:text=murine%20hepatitis%20virus%20%E2%80%93%20a,CoV%20antivirals')
66. AnnotationURLCitation(end_index=33890, start_index=33736, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=a%20novel%20membrane,Malectin%20preferentially%20associated%20with%20a')
67. AnnotationURLCitation(end_index=34489, start_index=34328, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=folding%20of%20nascent%20glycoproteins%2C%20ER,glycans%20are%20trimmed%20into')
68. AnnotationURLCitation(end_index=34652, start_index=34490, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=degradation%20via%20ubiquitination.,association%20mechanisms%20such%20as%20the')
69. AnnotationURLCitation(end_index=36100, start_index=35963, title='Role of malectin in Glc(2)Man(9)GlcNAc(2)-dependent quality control of α1-antitrypsin - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21813736/#:~:text=quality%20control%2C%20malectin%20is%20highly,Q3%29%20dose')
70. AnnotationURLCitation(end_index=36284, start_index=36101, title='Role of malectin in Glc(2)Man(9)GlcNAc(2)-dependent quality control of α1-antitrypsin - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21813736/#:~:text=Metabolic%20labeling%20and%20immunoprecipitation%20experiments,induced%20by%20tunicamycin%20results%20in')
71. AnnotationURLCitation(end_index=36606, start_index=36470, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=proteins.,the%20native%20form%2C%20suggesting%20that')
72. AnnotationURLCitation(end_index=36745, start_index=36607, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=OST%20complex.,complex%20with%20ribophorin%20I%2C%20as')
73. AnnotationURLCitation(end_index=37021, start_index=36913, title='S-EPMC3027649 - Malectin participates in a backup glycoprotein quality control pathway in the mammalian ER. - OmicsDI', type='url_citation', url='https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=residues,We')
74. AnnotationURLCitation(end_index=37186, start_index=37022, title='S-EPMC3027649 - Malectin participates in a backup glycoprotein quality control pathway in the mammalian ER. - OmicsDI', type='url_citation', url='https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=clients%20NHK%20and%20%3F1,the%20ER%20quality%20control%20machinery')
75. AnnotationURLCitation(end_index=37448, start_index=37343, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=membrane,type%20%28WT')
76. AnnotationURLCitation(end_index=37626, start_index=37449, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=demonstrated%20that%20like%20other%20molecular,molecular%20mechanisms%20by%20which%20malectin')
77. AnnotationURLCitation(end_index=37967, start_index=37823, title='The glycoprotein quality control factor Malectin promotes coronavirus replication and viral protein biogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11185542/#:~:text=murine%20hepatitis%20virus%20%E2%80%93%20a,CoV%20antivirals')
78. AnnotationURLCitation(end_index=38316, start_index=38142, title='Malectin, an endoplasmic reticulum-resident lectin, promotes malignant behavior of human hepatocellular carcinoma | Glycobiology | Oxford Academic', type='url_citation', url='https://academic.oup.com/glycob/advance-article/doi/10.1093/glycob/cwaf007/8030605#:~:text=%28ER%29%20stress%20conditions,HCC%20cells%20in%20nude%20mice')
79. AnnotationURLCitation(end_index=38615, start_index=38484, title='MLEC malectin [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&Db=gene&Term=9761#:~:text=1,PMID%2021813736%2C%20Free')